Advocacy Actions

2022-06-09 > Beijing, Shanghai

Comments to National Medical Products Administration (NMPA) on the Implementation Regulations of Drug Administration Law (Draft Revisions))

European Chamber submitted a 60-page long comment to the National Medical Products Administration (NMPA) on the Implementation Regulations of the Drug Administration Law of the People's Republic of China (Draft Revisions) on 9th June.

Read more
2022-04-28 > Beijing, Shanghai

Comments to the National Health Commission (NHC) on the Workplan for Temporarily Importing Drugs of Urgent Clinical Needs

The European Chamber submitted comments to the National Health Commission (NHC) on the Workplan for Temporarily Importing Drugs of Urgent Clinical Needs on 28th April.

Read more
2022-04-28 > Beijing, Shanghai

Sent Comments to the National Medical Products Administration (NMPA) on the Inspection Essentials for Drug Marketing Authorisation Holders

European Chamber submitted comments to the National Medical Products Administration (NMPA) on the Inspection Essentials for Drug Marketing Authorisation Holders on 28th April.

Read more
2022-04-21 > Beijing

Comments to MOST on the Implementing Rules of the Regulations for the Administration of Human Genetic Resources

On 21 April, the European Chamber submitted comments to the Ministry of Science and Technology on the Implementing Rules of the Regulations for the Administration of Human Genetic Resources.

Read more
2022-03-25 > All chapters

European Chamber Attended CCPIT 2022 First Quarter Online Seminar with FIEs

On 25th March, the European Chamber attended the 2022 First Quarter Online Seminar on Business Environment for Foreign-invested Enterprises in China, organized by the research department of the China Council for the Promotion of International Trade (CCPIT).

Read more
2021-12-14 > Beijing, Shanghai

Comments to National Health Commission (NHC) on the Administrative Measures of the National Essential Drugs List

On 14th December, European Chamber Pharmaceutical Working Group submitted comments to National Health Commission (NHC) on the Administrative Measures of the National Essential Drugs List.

Read more
2021-12-01 > Beijing

Meeting with Mr. Ramunas Freigofas, First Counsellor for Health and Food Safety of EU Delegation to China

European Chamber representatives from agriculture, EU affairs, food and beverage, cosmetics, healthcare equipment, pharmaceutical sectors, met with Mr. Ramunas Freigofas, First Counsellor for Health and Food Safety of EU Delegation to China to exchange work priorities of both sides and plan for further cooperation.

Read more
2021-11-26 > All chapters

Submission of Comments on Draft Measures on Security Assessment of the Cross-border Transfer of Data

At the end of October, the Cybersecurity Administration of China (CAC) published a invitation to public consultation on the Measures on Security Assessment of the Cross-border Transfer of Data (Draft for comments).

Read more
2021-11-25 > Beijing, Shanghai

Comments to National Health Commission (NHC) on the Regulatory Measures of Internet-based Diagnosis and Treatment (Draft for Comment)

On 25th November, European Chamber Pharmaceutical Working Group submitted comments to National Health Commission (NHC) on the Regulatory Measures of Internet-based Diagnosis and Treatment (Draft for Comment).

Read more
2021-10-24 > Beijing, Shanghai

Comments to the "Technical Specification for National Procedures and Services in Medicine" of the Health Development Reseach Institute

The Healthcare Equipment and the Pharmaceuticals Working Group submitted comments to the draft "Technical Specification for National Procedures and Services in Medicine", prepared by the Health Development Reseach Institute under the National Health Commission (NHC).

Read more